Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

DA Davidson Downgrades Grocery Outlet Holding to Neutral, Raises Price Target to $43

DA Davidson analyst Michael Baker downgrades Grocery Outlet Holding (NASDAQ:GO) from Buy to Neutral and raises the price target from $36 to $43.

byBenzinga Newsdesk

July 6, 2022

1 minute read

DA Davidson analyst Michael Baker downgrades Grocery Outlet Holding (NASDAQ:GO) from Buy to Neutral and raises the price target from $36 to $43.

Sanofi Earns Price Target Cut After Stopping Breast Cancer Drug Trial

By Vandana Singh

Today, 7:33 AM

Sanofi SA (NASDAQ:SNY) discontinued the development of its oral SERD amcenestrant following a negative interim analysis of the AMEERA-5…

PFE

Analyst Ratings

Analyst Ratings For Keysight Technologies

By Benzinga Insights

Today, 7:33 AM

Within the last quarter, Keysight Technologies (NYSE:KEYS) has observed the following analyst ratings:

KEYS

HIS, Brady Collaborate To Offer Safety Management Solution

By Akanksha Bakshi

Today, 7:33 AM

Brady Corp (NYSE:BRC) and HSI established a collaboration to bring configurable safety management solutions (SMS) and additional services to businesses of…

BRC

News

SK Bioscience and GSK Initiate Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate

By Charles Gross

Today, 7:33 AM

SK bioscience (SK) and GlaxoSmithKline plc (NYSE: GSK) today announced the initiation of a Phase 3 clinical study of SK's COVID-19 vaccine candidate, GBP510, in combination with GSK's pandemic adjuvant following positive interim Phase 1/2 results.

GSK

DA Davidson Downgrades Grocery Outlet Holding to Neutral, Raises Price Target to $43

Related Posts

Sanofi Earns Price Target Cut After Stopping Breast Cancer Drug Trial

Analyst Ratings For Keysight Technologies

HIS, Brady Collaborate To Offer Safety Management Solution

SK Bioscience and GSK Initiate Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate